AVI avails itself of Jayant Aphale as senior VP
This article was originally published in Scrip
Executive Summary
AVI BioPharma, a developer of RNA-based therapeutics, has appointed Dr Jayant Aphale senior vice-president of technical operations, with responsibility for all of AVI's internal and outsourced manufacturing activities. Dr Aphale brings over 18 years of cGMP technical operations and cross-functional leadership experiences, and most recently served as vice-president at GlaxoSmithKline in Belgium leading new product introductions, cGMP scale-up of clinical material manufacturing, US government interactions and global technology transfer of marketed vaccines.